enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Dyshidrosis - Wikipedia

    en.wikipedia.org/wiki/Dyshidrosis

    Dyshidrosis is diagnosed clinically by gathering a patient's history and making observations. [8] Allergy testing and culture may be done to rule out other problems. [8] Severity of symptoms can also be assessed using the dyshidrotic eczema area and severity index (DASI), although it was designed for clinical trials and is not typically used in ...

  3. Medication package insert - Wikipedia

    en.wikipedia.org/wiki/Medication_package_insert

    In Europe, the technical document is called the "summary of product characteristics" (SmPC), and the document for end-users is called the "patient information leaflet" (PIL) or "package leaflet". [3] Similar documents attached to the outside of a package are sometimes called outserts. [citation needed]

  4. Pompholyx - Wikipedia

    en.wikipedia.org/wiki/Pompholyx

    Pompholyx may refer to: Pompholyx, certain eczema, see dyshidrosis; Pompholyx, a genus of rotifers in the family Testudinellidae; Pompholyx, a genus of insects in the family Pneumoridae, synonym of Prostalia; Pompholyx, a genus of fungi in the family Sclerodermataceae, synonym of Scleroderma

  5. Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss - AOL

    www.aol.com/finance/eli-lilly-scores-fda...

    Friday, the FDA approved Eli Lilly And Co’s (NYSE:LLY) Ebglyss (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for adults and children 12 years of age and older who weigh at least 88 pounds (40 ...

  6. Id reaction - Wikipedia

    en.wikipedia.org/wiki/Id_reaction

    Although there are a multitude of varying appearances, the id reaction often presents with symmetrical red patches of eczema with papules and vesicles, particularly on the outer sides of the arms, face and trunk which occur suddenly and are intensely itchy occur a few days to a week after the initial allergic or irritant dermatitis.

  7. EBGLYSS for eczema: What to know about the newly FDA ... - AOL

    www.aol.com/ebglyss-eczema-know-newly-fda...

    A newly approved drug for the treatment of atopic dermatitis could make a big difference to people with moderate-to-severe eczema. Image credit: Sascha Lotz/picture alliance via Getty Images.

  8. FDA puts on hold two drug trials of Rapt Therapeutics in ...

    www.aol.com/news/fda-puts-hold-two-rapt...

    (Reuters) -Rapt Therapeutics said on Tuesday the U.S. FDA had placed on hold two mid-stage trials of the company's drug to treat eczema and asthma, after liver failure was observed in one of the ...

  9. Hand eczema - Wikipedia

    en.wikipedia.org/wiki/Hand_eczema

    Severe hand eczema is characterised by consistent or recurring, extended inflammation of the skin that severely affects the patient. Hand eczema is described as chronic if it lasts at least 3 months in spite of dermatological treatment, or if it recurs at least twice within a period of 12 months . Severe and chronic patterns of hand eczema are ...